Joscelyn Mejías is an assistant professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University. She received a BS in bioengineering with the Distinction in Research and Creative Works and a BA in asian studies from Rice University; she earned her MS and Ph.D. from the joint Wallace H. Coulter Department of Biomedical Engineering at the Georgia Institute of Technology and Emory University. Mejías has been supported by a number of awards including the GT Presidents Fellowship and Goizueta Foundation Fellowship, NSF-GRFP, and Alfred P. Sloan Foundations Minority Ph.D. Fellowship. She has received the 2023 L’Oréal For Women in Science for her work in Uterine Fibroids and NIA MOSAIC K99 to study age and sex differences in the immune response to biomaterials. Her lab focuses on biomaterials, immune mediated tissue regeneration, and developing in vitro models of fibrosis (uterine fibroids).

Our interests lie in the adhesion and signaling molecules of the immune system as well as those involved in platelet adhesion and aggregation. We are primarily focused on early cell surface interaction kinetics and their primary signaling responses, as these are critical in determining how a cell will ultimately respond upon contact with another cell. The majority of our work ranges from single molecule interaction studies using atomic force microscopy, molecular dynamics simulations, or biomembrane force probe assays to single cell studies using micropipette adhesions assays, fluorescence imaging techniques, or real-time confocal microscopy. These assays focus on the mechanics and kinetics of receptor-ligand binding and their downstream signaling effects within cells. T cell receptors, selectins, integrins, and their respective ligands are some of the cell surface molecules currently under investigation in our lab. Understanding the initial interaction between molecules such as these and their subsequent early signaling processes is crucial to elucidating the response mechanisms of these physiological systems. Ultimately, our research strives to help better understand the mechanisms within these systems for possible medical applications in autoimmunity, allergy, transplant rejection, and thrombotic disorders. 

Xia is the Brock Family Chair and Georgia Research Alliance (GRA) Eminent Scholar in Nanomedicine in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Institute of Technology and Emory University, with joint appointments in School of Chemistry and Biochemistry, and School of Chemical and Biomolecular Engineering. Professor Xia received his Ph.D. degree in Physical Chemistry from Harvard University (with Professor George M. Whitesides) in 1996, his M.S. degree in Inorganic Chemistry from University of Pennsylvania (with the late Professor Alan G. MacDiarmid, a Nobel Laureate in Chemistry, 2000) in 1993, and his B.S. degree in Chemical Physics from the University of Science and Technology of China (USTC) in 1987. He came to the United States of America in 1991. Xia has received a number of prestigious awards, including the 2013 Nano Today Award, the ACS National Award in the Chemistry of Materials (2013), Fred Kavli Distinguished Lecture in Nanoscience at the MRS Spring Meeting (2013), AIMBE Fellow (2011), MRS Fellow (2009 ), NIH Director's Pioneer Award (2006), ACS Leo Hendrik Baekeland Award (2005), Camille Dreyfus Teacher Scholar (2002), David and Lucile Packard Fellowship in Science and Engineering (2000), Alfred P. Sloan Research Fellow (2000), NSF Early Career Development Award (2000), ACS Victor K. LaMer Award (1999), and Camille and Henry Dreyfus New Faculty Award (1997). Xia has been an Associate Editor of Nano Letters since 2002, and has served on the Advisory Boards of Particle & Particle Systems Characterization (2013-), Chemical Physics Letters (2013-), Chemistry: A European Journal (2013-), Chinese Journal of Chemistry (2013-), Angewandte Chemie International Edition (2011-), Advanced Healthcare Materials (2011-, inaugural chairman of the advisory board), Accounts of Chemical Research (2010-), Cancer Nanotechnology (2010-), Chemistry: An Asian Journal (2010-), Journal of Biomedical Optics (2010-), Nano Research (2009-), Science of Advanced Materials (2009-), Nano Today (2006-), Chemistry of Materials (2005-2007), Langmuir (2005-2010, 2013-2015), International Journal of Nanotechnology (2004-), and Advanced Functional Materials (2001-). He has also served as a Guest Editor of special issues for Advanced Materials (six times), Advanced Functional Materials (one time), MRS Bulletin (one time), and Accounts of Chemical Research (one time).

May Dongmei Wang, Ph.D., is The Wallace H Coulter Distinguished Faculty Fellow, professor of BME, ECE and CSE, Director of Biomedical Big Data Initiative, and Georgia Distinguished Cancer Scholar. She is also Petit Institute Faculty Fellow, Kavli Fellow, Fellow of AIMBE, Fellow of IEEE, and Fellow of IAMBE. She received BEng from Tsinghua University China and MS/PhD from Georgia Institute of Technology (GIT). Dr. Wang’s research and teaching are in Biomedical Big Data and AI-Driven Biomedical Health Informatics and Intelligent Reality (IR) for predictive, personalized, and precision health. She has published over 270 referred journal and conference proceeding articles (13,500+ GS-Citations) and delivered over 280 invited and keynote lectures. Dr. Wang’s research has been supported by NIH, NSF, CDC, GRA, GCC, VA, Children’s Healthcare of Atlanta, Enduring Heart Foundation, Wallace Coulter Foundation, Carol Ann and David Flanagan Foundation, Shriner’s Hospitals, Microsoft Research, HP, UCB, and Amazon.

Dr. Wang chairs IEEE Engineering in Medicine and Biology Society (EMBS) BHI-Technical Community and ACM Special Interest Group in Bioinformatics (SIGBio), and is the Senior Editor of IEEE Journal of Biomedical & Health Informatics (IF=7.02), and Associate Editor for IEEE Transactions on BME, and IEEE Review of BME. She was IEEE EMBS Distinguished Lecturer and PNAS (Proceeding of National Academy of Sciences) Emerging Area Editor. During the past decade, Dr. Wang has been a standing panelist for NIH Study Sections, NSF Smart and Connect Health, and Brain Canada, and has co-chaired and helped organize more than 10 conferences by IEEE Engineering in Medicine and Biologics  Gordon Research Conferences, ACM Special Interest Groups in Bioinformatics, and IEEE Future Directions.

Dr. Wang received GIT Outstanding Faculty Mentor for Undergrad Research Award and Emory University MilliPub Award for a high-impact paper cited over 1,000 times. She was selected into 2022 Georgia Tech LeadingWomen Program and 2021 Georgia Tech Provost Emerging Leaders Program. Previously, she was Carol Ann and David Flanagan Distinguished Faculty Fellow, GIT Biomedical Informatics Program Co-Director in ACTSI, and Bioinformatics and Biocomputing Core Director in NIH/NCI-Sponsored U54 Center for Cancer Nanotechnology Excellence.

Eberhard Voit’s research interests are in the area of complex biomedical systems. Work in his lab focuses on genomic, metabolic, and signaling systems with applications reaching from microbial and plant systems to human diseases. Voit has authored or co-authored about two hundred fifty scientific articles and book chapters as well as several books. Voit is an elected a fellow in the American Institute for Medical and Biological Engineering (AIMBE) and the American Association for the Advancement of Science (AAAS).

Denis Tsygankov, PhD, is Assistant Professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech School of Engineering and Emory University School of Medicine. 

Dr. Tsygankov is interested in developing and applying computational methods, including mathematical modeling, simulations, and computer vision approaches to understand complex multi-scale physiological processes including vasculogenesis, morphogenesis, and cancer. 

He is a member of the Cell and Molecular Biology Research Program at Winship Cancer Institute.

I am an engineer and neuroscientist focused on how the brain and body cooperate to allow us to move. Fundamental abilities like standing and walking appear effortless until we–or someone we love–loses that ability. Movement is impacted in a wide range of diseases because it involves almost all parts of the brain and body, and their interactions with the environment. How we move is also highly individualized, changing across our lifetimes as a function of our experiences, and adapting in different situations. As such, assessing and treating movement impairments remains highly challenging. My approach is to dissect the complexities of how we move in health and disease by bridging what may seem to be disparate fields across engineering, neuroscience, and physiology. Our current application areas are Parkinson’s disease, stroke, aging and cerebral palsy, and we are interested in extending our work toward mild cognitive impairment and concussion.

My lab uses robotics, computation, and artificial intelligence to identify new physiological principles of sensing and moving that are enabling researchers to personalize rehabilitation and medicine. Primarily, we study people in the lab, studying brain and muscle activity in relationship to the body’s biomechanics in standing and walking. We use and develop robotic devices for assessing and assisting human movement, while interpreting brain and muscle activity to personalize the interactions. Our novel computer simulations of muscle, neurons, and joints establish a virtual platform for predicting how movements change in disease and improve with interventions. Recently, we have demonstrated the critical role of cognitive function motor impairment that may increase fall risk, suggesting that how we move and how we think may be closely related. Current projects include developing physiologically-inspired controllers to enable exoskeletons to enhance user balance, identifing individual differences that predict response to gait rehabilitation in stroke survivors, and developing more precise and physiologically-based methods to interpret clinical motor test outcomes.

Dr. Johnna S. Temenoff is the Carol Ann and David D. Flanagan Professor at the Coulter Department of Biomedical Engineering at Georgia Tech/Emory University. She is also currently the Director of the NSF Engineering Research Center in Cell Manufacturing Technologies (CMaT) and the Director of the Marcus Center for Therapeutic Cell Characterization and Manufacturing (MC3M). Scientifically, Dr. Temenoff is interested in scaling culture of therapeutic cells and tailoring the molecular interactions between glycosaminoglycans and proteins/cells for use in regenerative medicine applications.  Her laboratory focuses primarily on promoting repair after injuries to the tissues of the shoulder, including cartilage, tendon, and muscle.

Dr. Temenoff has been honored with several prestigious awards, such as the NSF CAREER Award, Arthritis Foundation Investigator Award, and Society for Biomaterials (SFB) Clemson Award for Contributions to the Literature, and was named to the College of Fellows of the American Institute for Medical and Biological Engineers (AIMBE), as a Fellow of the Biomedical Engineering Society (BMES), as a Fellow of the International Academy of Medical and Biological Engineering (IAMBE) and as a Fellow of Biomaterials Science and Engineering, International Union of Societies for Biomaterials Science and Engineering (IUSBSE).  She has co-authored a highly successful introductory textbook - Biomaterials: The Intersection of Biology and Materials Science, by J.S. Temenoff and A.G. Mikos (now in a 2nd edition), for which Dr. Temenoff and Dr. Mikos were awarded the American Society for Engineering Education’s Meriam/Wiley Distinguished Author Award for best new engineering textbook. 

Shu Takayama earned his BS and MS in Agricultural Chemistry at the University of Tokyo. He earned a Ph.D. in Chemistry at The Scripps Research Institute in La Jolla, California studying bio-organic synthesis with Dr. Chi‐Huey Wong. He then worked as a postdoc with Dr. George Whitesides at Harvard University where he focused on applying microfluidics to studying cell and molecular biology.

Takayama began his career at the University of Michigan, where led his lab in the Department of Biomedical Engineering and Macromolecular Science & Engineering for over 17 years. In 2017, the lab moved to Georgia Tech where Shu became the Georgia Research Alliance Price Gilbert Chair Professor of Biomedical Engineering in the Wallace H. Coulter Department of Biomedical Engineering.

Takayama’s research interests are diverse and motivated by clinical and biotechnology needs. He is always interested in hearing from stakeholders in these areas who are seeking engineering collaboration.